CancerSep 3, 2026
A 3D mammogram is still a mammogram, but it takes X-ray images from several angles and rebuilds the breast into thin slices, so overlapping tissue is less likely to hide a cancer or mimic one. In practice it usually finds a little more cancer, especially invasive tumors, and in U.S. clinics it often means fewer callbacks for a second look. What it hasn't yet clearly proven is that catching those extra cancers leads to fewer interval cancers, advanced cancers, or breast cancer deaths for most women. If 3D is available and covered, it's a reasonable choice; if only 2D is available or affordable, the mammogram you actually get on schedule matters far more than which machine takes it.
NewsAug 31, 2026
Antibiotics keep failing because in many women the recurring problem is no longer a simple infection. A 2026 chart review of 253 women referred to a specialty clinic for persistent urogenital symptoms found only about 15% had a classic urologic cause. The rest had hormonal changes at the vaginal opening and pelvic floor, or bacteria embedded where standard urine cultures don't see them. What breaks the cycle is treating that driver: vaginal estrogen after menopause, a pelvic floor and vulvovaginal evaluation when cultures keep coming back negative, and a workup that reaches past another prescription.
MedicationAug 17, 2026
If your PCOS is tied to higher weight or insulin resistance, a GLP-1 medicine like semaglutide may help the metabolic driver behind some of your symptoms, and better periods or lower testosterone may follow. But Ozempic is not a PCOS drug, and it is not a proven fertility treatment. The reliable part is weight loss and metabolic improvement; the reproductive claims come from small, short trials. If pregnancy is possible, timing matters: the PCOS guideline calls for effective contraception during GLP-1 use, and the Ozempic label advises stopping at least two months before a planned pregnancy.
Women's HealthAug 16, 2026
If severe period pain, pelvic pain, or pain with sex is disrupting your life, endometriosis is one of the main explanations to consider, and you no longer have to wait for surgery to find out. Symptoms, a pelvic exam when appropriate, and ultrasound or MRI can be enough to start treatment now. It affects about 1 in 10 women of reproductive age. If you fit the pattern, this is a common answer, not a rare one.
Women's HealthAug 16, 2026
Hormone therapy hasn't been shown to prevent Alzheimer's. It earns its place for menopausal symptoms and bone protection, and the newer estrogen-and-brain studies matter on their own terms: some women using hormones show lower tau markers and larger brain regions tied to Alzheimer's risk. But no trial that tracks actual diagnoses has found fewer cases, and starting combined hormones at 65 or older raised dementia risk in the largest randomized dementia trial. Timing and formulation matter more than a simple yes or no.
FertilityAug 12, 2026
No, 36 isn't too late. It sits past your easiest biological years but before the steeper drop often seen after about 38. What matters now isn't whether freezing can help. It's whether you can bank enough mature eggs soon enough to make it worth it, which often takes more than one cycle.
Colon CancerJun 4, 2026
Colorectal cancer stands as one of the deadliest cancers worldwide, yet it is also one of the most preventable. For women, the story of prevention often begins with a single procedure: the colonoscopy. More than just a diagnostic tool, the evidence from large-scale studies, clinical trials, and decades of clinical practice strongly suggests that the colonoscopy is indispensable for early detection in women.
MammogramJun 4, 2026
Somewhere between 60% and 90% of women report at least some pain or discomfort during breast compression, depending on the study. That number is high, and it deserves an honest answer rather than dismissal. But the intensity and duration matter just as much as the frequency: most women rate the pain as mild to moderate, it resolves within minutes of the plates releasing, and only about 6 to 8% of women in large screening groups report severe pain, defined as a 7 or higher on a 0-to-10 scale.
So the truthful answer is: it will probably hurt some, it probably won't hurt a lot, and it will be over fast.
InfectionsJun 4, 2026
Somewhere between 20% and 40% of women of reproductive age carry Ureaplasma parvum in their genital tract, and most of them will never know it, never have symptoms, and never need treatment. A major European guideline found no evidence that routine testing and treatment of asymptomatic adults does more good than harm. So why does this tiny bacterium keep showing up in lab results and online forums?
Because context matters. In specific situations, particularly certain pregnancies, some infertility cases, and rare invasive infections in vulnerable people, U. parvum shifts from silent freeloader to genuine concern. The challenge is knowing which situation you're actually in.
HormonesJun 4, 2026
Estradiol patches push hormone replacement through your skin and directly into your bloodstream, completely skipping your gut and your liver's first pass at metabolizing it. That single difference reshapes the safety profile in meaningful ways: lower impact on liver proteins, generally lower risk of venous thromboembolism (VTE, or blood clots in veins) compared to swallowing the same hormone in pill form, and steadier estradiol levels instead of the peaks and valleys that come with oral dosing.
But "safer metabolic profile" doesn't mean "no tradeoffs." Patches come with their own set of practical headaches, from skin irritation to adhesive failure to supplement interactions most people never hear about. Here's how it all shakes out.
ColonoscopyJun 4, 2026
Colonoscopy was not designed with women's bodies in mind, and the data reflects it. Women have anatomically longer, more redundant colons that make the procedure technically more difficult. They report more pain. Their colorectal lesions are harder to detect. And perhaps most critically, a negative colonoscopy after a positive stool test reduces subsequent colorectal cancer incidence in men but offers a much weaker, or even absent, protective effect in women.
These aren't minor footnotes. They point to real, measurable gaps in how well colonoscopy serves half the population, from the moment of referral through follow-up.
Cancer ScreeningJun 4, 2026
Human papillomavirus (HPV) is the central causative agent of cervical cancer and also contributes to other anogenital and head and neck cancers. Traditional methods of detection, such as HPV DNA testing, provide evidence of infection but do not always distinguish between transient infections that may clear spontaneously and those likely to progress toward malignancy. This is where mRNA testing for the viral oncogenes E6 and E7 has emerged as a promising biomarker. Unlike DNA-based methods, E6/E7 mRNA detection reflects the transcriptional activity of high-risk HPV, directly indicating the virus’s oncogenic potential.
MenopauseJun 4, 2026
A dose as small as 15 micrograms of estradiol, applied vaginally as a 0.003% cream, measurably improves dryness, painful sex, vaginal pH, and cell health compared to placebo over 12 weeks. That's a remarkably small amount of hormone doing real, measurable work right where it's needed, with generally low systemic exposure. The practical upside: for most postmenopausal women dealing with vaginal symptoms, estradiol cream can offer targeted relief without necessarily sending estrogen levels surging through the rest of the body.
But "generally low" systemic absorption isn't the same as zero. How much estrogen actually reaches your bloodstream depends on the dose, the route, the formulation, and even whether the product is FDA-approved or compounded. Those details matter, especially if you have a history of hormone-sensitive cancer.
HormonesJun 3, 2026
Dehydroepiandrosterone sulfate (DHEA-S) is one of the most abundant steroid hormones in the human body. Produced mainly by the adrenal glands, it acts as a precursor to both estrogens and androgens. In women, levels of DHEA-S usually peak in early adulthood and then decline steadily over time. So when elevated levels appear later in life, they raise important questions. What is this hormone trying to tell us and why does it matter?
Urinary HealthJun 3, 2026
Vaginal discharge during a suspected urinary tract infection is one of the most misread signals in everyday health. Rather than confirming a UTI, noticeable vaginal discharge in adult women actually lowers the probability that a UTI is causing your symptoms. Diagnostic research puts the likelihood ratio at roughly 0.3 to 0.7 when vaginal discharge is present, meaning it shifts the odds meaningfully away from a simple bladder infection and toward a vaginal or sexually transmitted cause.
That single clue can save you a wrong guess, a wrong treatment, and a frustrating cycle of symptoms that don't resolve. Here's how discharge patterns map onto what's actually going on.
Cancer ScreeningJun 3, 2026
For decades, mammography has been considered the gold standard for breast cancer screening, particularly in women over the age of 40. Yet, as technology advances and as researchers examine the limitations of mammography, ultrasound has emerged as a critical complementary tool and, in certain contexts, a potential alternative. Understanding what each modality truly reveals about early cancer detection carries profound consequences for both risk assessment and personal decision-making.
NutrientsJun 2, 2026
Pregnancy is a physiological paradox: the body is both at its most generative and its most vulnerable. During these nine months, a woman’s nutrient demands surge as her body builds an entirely new human being while maintaining her own health. The body becomes an alchemist, converting diet and stored reserves into life. Yet the balance is delicate. Too little of key micronutrients such as folate, vitamin D, iron, and B12, and cells falter in replication and repair. Too much, and metabolism tips into toxicity. The modern prenatal vitamin exists to steady this biochemical dance.
But how do the best prenatal vitamins actually work to minimize risk and support maternal longevity? The answer lies not in isolated “super nutrients” but in the way these compounds orchestrate growth, immunity, and metabolic stability across two generations.
ProbioticsJun 2, 2026
Most vaginal probiotic marketing suggests a single product can fix a wide range of problems: yeast infections, odor, pH balance, even fertility. The clinical research tells a much narrower story. Evidence moderately supports certain Lactobacillus-based probiotics as add-ons to antibiotic treatment for bacterial vaginosis (BV) and, to a lesser extent, for reducing recurrent urinary tract infections. For yeast infections, pregnancy outcomes, and general "vaginal wellness," the data range from weak to flatly negative.
There's another uncomfortable truth buried in the research: benefits from vaginal probiotics rarely persist once you stop using them. The probiotic strains detected during treatment tend to disappear after dosing ends, which raises a real question about what long-term value most products actually deliver.
PCOSJun 2, 2026
Letrozole was designed to treat breast cancer. But in head-to-head comparisons against clomiphene, the drug that dominated fertility treatment for over 50 years, letrozole produced higher ovulation rates, higher pregnancy rates, and more live births in women with PCOS. That shift was significant enough for international guidelines to now recommend letrozole as the first-line medication for ovulation induction in PCOS.
What makes this especially notable is that letrozole isn't just more effective in key populations. It also tends to produce single-follicle ovulation rather than multiple follicles, which translates to fewer twins and triplets. For anyone weighing fertility treatment options, that combination of better outcomes with lower risk of multiples is worth understanding.
CreatineJun 2, 2026
If you've spent any time browsing creatine supplements marketed to women, you've probably noticed a pattern: fancy formulations, pastel packaging, and price tags that climb with every added buzzword. The research tells a much simpler story. Plain creatine monohydrate, the same form that's been studied for decades, is the most effective, safest, and most affordable option for women at every life stage.
This article will help you answer the practical questions: Which type of creatine should you actually buy? How much do you need to take? Will it make you bloated? And does the answer change depending on your age or goals?
